OS 27 is the next major iPhone software version, here’s when to expect its release—including dates for the first betas and ...

As part of its interoperability compliance in the EU, Apple has been working on changes to iOS that allow AirPods-like ...

Apple has updated its Developer Program License Agreement with new rules on how third-party accessories must handle forwarded ...

With the new iPhone 17 models in customers’ hands and iOS 26 finding its way to hundreds of millions of iPhones, it’s time to move on to the first major update to Apple’s iPhones: iOS 26.1. Apple ...

DEXTER, MI — A plan for the City of Dexter to sell a piece of downtown to a residential and commercial developer has faced a delay, but developers are optimistic they will be able to move forward.

Apple's fourth round of developer betas has arrived, with builds of iOS 26.4, iPadOS 26.4, watchOS 26.4, tvOS 26.4, visionOS 26.4, and macOS Tahoe 26.4 now available for testing. The first iOS 26.4 ...

Apple released iOS 26.3.1 for the iPhone on Wednesday -- a small patch that arrives a few weeks after the rollout of iOS 26.3, focusing mainly on fixes and under-the-hood improvements. The update is ...

In an open letter to Google and the Android developer community, Keep Android Open argues that the new policy threatens innovation, competition, privacy, and user freedom. Google’s planned Android ...

Feb 18 (Reuters) - Unnatural Products said on Wednesday it has signed a licensing agreement with Novartis (NOVN.S), opens new tab to develop macrocyclic peptide-based therapies for a cardiovascular ...

BRISBANE, Australia & BOSTON--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced that it has entered ...

Apple Issues Urgent Software Fix Affecting Over 2 Billion iPhones Your email has been sent Apple has rolled out a wave of urgent software updates… and this time, the warning signs are hard to ignore.

Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing Pfizer (PFE.N), opens new tab access to its technology that boosts immune responses to vaccines ‌for use in up to ...